
DDW Fall 2022
The Fall 2022 issue of DDW combines innovation and analysis in drug discovery and development. This issue highlights the neuroscience sector. Read More

The Fall 2022 issue of DDW combines innovation and analysis in drug discovery and development. This issue highlights the neuroscience sector. Read More

The Summer 2022 issue of DDW combines the latest innovation, business-critical content and analysis in drug discovery and development. Articles cover an immunotherapy for bladder cancer, DNA sequencing within the human genome and advances in mass spectrometry technology. Read More

The Spring 2022 issue of DDW combines the latest innovation, business-critical content and analysis in drug discovery and development. Articles cover using animal genomics to find human therapies and exploring the microbiome. Read More

The Winter 2021/2022 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles cover quantum computing and why targeted protein degradation is so exciting. Read More

The Fall 2021 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles cover insight into Chinese drug discovery, engineering antibodies and clinical trials. Read More

The Summer 2021 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles cover the rise of Swiss biotech, informatics and genomics. Read More

The Spring 2021 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles cover the importance of collaboration in drug discovery, cell painting, and antibodies. Read More

The Winter 2020/21 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles include advances in vaccines and virology, assay expertise and focusses on AI and US biotech. Read More

The Fall 2020 issue of DDW combines the latest innovation, opinion, business-critical content and analysis in drug discovery and development. Articles include COVID-19 advances, a focus on assays, business opportunities plus interviews with key figures. Read More

This issue looks at the race to find the Covid-19 cure and we ask – will the next generation of CAR-T cells be modified using base editing? It also outlines creating vaccines drop by drop. Read More

This issue features target discovery and drug development – what comes after CRISPR? It also covers reprogramming stem cells for new cures and the benefits of sharing compound solubility data. Read More